AUDIENCES Proves Model for Pharma, Life Sciences & Medtech with Major Global Client Win

AUDIENCES, the industry’s answer to data privacy and security first-party data activation, swoops to win a global contract to support Becton Dickinson in driving advertising excellence.  

Pharma, life sciences, and medical technology verticals have long had an unmet need, to safely and compliantly leverage intelligence across digital advertising. Understandably these industries have required increasingly higher standards for data privacy and security in line with regulation and consumer expectation on both sides of the Atlantic. To meet these needs AUDIENCES delivers a complete solution enabling the activation of first part data. 

In a major signal of industry appetite for data privacy and security orientated solutions the global medical technology and life sciences organisation Becton Dickinson (BD) have chosen AUDIENCES as their long-term partner for first party data activation. The opportunities across markets and product areas are rich and diverse with significant value identified. Building on existing strong foundations of data and media activation will be swift and confident. Headquartered in New Jersey, United States, this BD is a further addition to AUDIENCES footprint within North America. 

Commenting on this news AUDIENCES CEO Rob McLaughlin said, “This win represents a major step forward for the industry, bringing the safest and most compliant approach to first-party data activation to verticals which have been crying out for more relevant and performant advertising. Pharma, life sciences, and medtech have long been close to our heart, adjacent to other regulated industries who prize data privacy and security whilst needing to drive effective marketing and advertising.”